The WHO Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders provides a comprehensive snapshot of global trends in alcohol consumption, related harms, and national policy responses, alongside the availability...
This publication presents key findings from the 8th round of the European School Survey Project on Alcohol and Other Drugs (ESPAD), conducted in 2024 among 113,882 students aged 15–16 across 37 European countries.
Marking 30 years of...
Recent data from the U.S. highlights a concerning rise in substance use and related harms. In 2022, over 109,000 drug overdose deaths were recorded—a 54% increase since 2019. The majority involved illicit fentanyl, often mixed with...
Europol’s EU Serious and Organised Crime Threat Assessment (EU-SOCTA) 2025, published today, reveals how the very DNA of crime is shifting – reshaping the tactics, tools and structures employed by criminal networks.
The EU-SOCTA offers one...
The Canadian Community Epidemiology Network on Drug Use (CCENDU), co-ordinated by the Canadian Centre on Substance Use and Addiction (CCSA), publishes this newsletter regularly to inform people living in Canada about emerging substance use...
The National Survey of Substance Use and Mental Health Services (N-SUMHSS) is a voluntary, annual survey that collects data from all active substance use and mental health treatment facilities across the United States, its territories, and...
EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment...
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of...
"The Challenge of New Psychoactive Substances – A Technical Update 2024" is an update of the UNODC publication “The Challenge of New Psychoactive Substances (NPS), 2013”, which focuses on the new psychoactive substances (NPS) encountered on...
The report summarises the evidence drawn from worldwide evidence reviews, mathematical modelling, and extensive consultations and discussions. The Guidance provides people in Canada with accurate and current information about the risk of...
The report, "Clearing the Smoke on Cannabis: Medical Use of Cannabis and Cannabinoids 2024 Update," examines the medical use of cannabis and cannabinoids, emphasizing their effects, efficacy, and the need for more rigorous research. Key...
Stimulants are a class of drugs that act on the central nervous system, increasing alertness, energy, and attention while elevating mood. They achieve these effects by enhancing the activity of neurotransmitters such as dopamine and...
Specific patterns of substance use have been found to correlate with an elevated risk of suicidal thoughts, attempts, and mortality by suicide. However, this relationship is multifaceted and influenced by various intersecting factors...
The Cannabis, Mental Health, and Substance Use Health: Research Knowledge Exchange Event Summary Report presents the findings and themes discussed at an event jointly hosted by CCSA (Canadian Centre on Substance Use and Addiction) and the...
Read key findings from the 2022 National Survey on Drug Use and Health (NSDUH). This report highlights 2022 statistics on substance use, mental health, and treatment in the United States. These national indicators are measured...
